GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (FRA:VTFN) » Definitions » EV-to-EBITDA

Vitrolife AB (FRA:VTFN) EV-to-EBITDA : -7.04 (As of May. 26, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Vitrolife AB's enterprise value is €2,283.2 Mil. Vitrolife AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was €-324.3 Mil. Therefore, Vitrolife AB's EV-to-EBITDA for today is -7.04.

The historical rank and industry rank for Vitrolife AB's EV-to-EBITDA or its related term are showing as below:

FRA:VTFN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -7.86   Med: 39.68   Max: 152.15
Current: -7.35

During the past 13 years, the highest EV-to-EBITDA of Vitrolife AB was 152.15. The lowest was -7.86. And the median was 39.68.

FRA:VTFN's EV-to-EBITDA is ranked worse than
100% of 488 companies
in the Medical Devices & Instruments industry
Industry Median: 16.205 vs FRA:VTFN: -7.35

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), Vitrolife AB's stock price is €15.95. Vitrolife AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.541. Therefore, Vitrolife AB's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Vitrolife AB EV-to-EBITDA Historical Data

The historical data trend for Vitrolife AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB EV-to-EBITDA Chart

Vitrolife AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.04 49.78 134.23 27.50 -8.64

Vitrolife AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.64 48.39 34.28 -8.64 -7.86

Competitive Comparison of Vitrolife AB's EV-to-EBITDA

For the Medical Devices subindustry, Vitrolife AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's EV-to-EBITDA falls into.



Vitrolife AB EV-to-EBITDA Calculation

Vitrolife AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2283.169/-324.285
=-7.04

Vitrolife AB's current Enterprise Value is €2,283.2 Mil.
Vitrolife AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-324.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vitrolife AB  (FRA:VTFN) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Vitrolife AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=15.95/-2.541
=At Loss

Vitrolife AB's share price for today is €15.95.
Vitrolife AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.541.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Vitrolife AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Vitrolife AB (FRA:VTFN) Business Description

Traded in Other Exchanges
Address
Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB (FRA:VTFN) Headlines

No Headlines